[A case of intrahepatic cholangiocarcinoma effectively treated by hepatic arterial infusion chemotherapy]

Gan To Kagaku Ryoho. 2006 Nov;33(11):1657-9.
[Article in Japanese]

Abstract

The patient was a 50-year-old woman who suffered from gastric discomfort. She was first diagnosed as intrahepatic cholangiocarcinoma with hepatic, paraaortic lymphnodal and bone metastasis. Initial systemic chemotherapy using gemcitabine (GEM) and 5-FU failed to control the disease activity. Then she was given GEM and cisplatin (CDDP) combination chemotherapy. The response was assessed as stable disease (SD), but grade 4 leukopenia was seen. Then systemic therapy using GEM, and hepatic arterial infusion therapy with CDDP, l-leucovorin and 5-FU were continued biweekly. Partial response (PR) was achieved six months later, and her disease status was maintained as SD. This hepatic arterial infusion chemotherapy would be safe and feasible as therapy for inoperable intrahepatic cholangiocarcinoma.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bile Duct Neoplasms / drug therapy*
  • Bile Duct Neoplasms / pathology
  • Bile Ducts, Intrahepatic*
  • Bone Neoplasms / secondary
  • Cholangiocarcinoma / drug therapy*
  • Cholangiocarcinoma / secondary
  • Cisplatin / administration & dosage
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Drug Administration Schedule
  • Female
  • Fluorouracil / administration & dosage
  • Gemcitabine
  • Hepatic Artery
  • Humans
  • Infusion Pumps, Implantable*
  • Infusions, Intra-Arterial
  • Leucovorin / administration & dosage
  • Lymph Nodes / pathology
  • Lymphatic Metastasis
  • Middle Aged

Substances

  • Deoxycytidine
  • Cisplatin
  • Leucovorin
  • Fluorouracil
  • Gemcitabine